QuickVue® Influenza A+B Test, Dipstick Format, Identifies Type A, Type B, or Both, Two-Color Endpoint, CLIA Waived
Due to FDA regulations, this product needs to be shipped to a CLIA-Waived or Moderately Complex licensed location.
We kindly ask that you provide an licensed facility address during checkout to ensure prompt delivery.
Thank you for your understanding and cooperation.
description
The QuickVue Influenza A+B Test detects and differentiates influenza type A and type B antigens directly from nasal swab and nasopharyngeal swab specimens. A single sample can be used to run both the QuickVue Influenza A+B Test and QuickVue RSV10 Test.
|
Sample type
|
Nasal swab, nasopharyngeal swab |
|
Time to
results
|
10 minutes or less |
|
Kit storage
conditions
|
Room temperature (15°C to 30°C/59°F to 86°F) |
|
Internal
controls
|
Positive and negative included |
|
External
controls
|
Positive and negative included |
|
PPA* (versus an FDA-cleared
influenza A and B molecular assay)
|
A: 81.5%, B: 80.9% |
|
NPA* (versus an FDA-cleared
influenza A and B molecular assay)
|
A: 97.8%, B: 99.1% |
|
Shelf life
|
24 months from date of manufacture |
|
Transport Media
Compatibility
|
BD Universal Viral Transport Media, Bartels Flextrans Media, Copan Universal Transport Media, Hank’s Balanced Salt Solution, M5 Media, Saline |
|
CLIA
complexity
|
Waived |
